Gerard Ryan
No reply on file from Gerard Ryan on this matter.
Claims entered
No claim has been entered on this docket.
1 filed · 1 on the record. The chronology below carries every filing, docket event and outcome — open a row there for its source.
Open to posting — anyone may add to this file, subject to the review queue.
The chronology
Gov, Institution and Public name who produced a document; Event marks a thing that happened, not a document.
1 entry of another class is hidden by this filter — show every class.
By when it happened. Rows with no date on their face are shown as undated, not guessed. Hover, focus or tap a row for its full detail.
Opened at stage filed
No crime on the record yet.
No statutes on the record yet.
"District Court for the Southern District of New York entered a bifurcated consent judgment as to Gerard Ryan of Oxford, Mississippi, whom the SEC previously charged with insider trading in the securities of biopharmaceutical company Kadmon Holdings, Inc. in advance of the company’s July 16, 2021 announcement that the Food and Drug Administration had approved Kadmon’s drug Rezurock."
"Ryan previously pled guilty to one count of securities fraud in a parallel criminal action brought by the U.S."
No parties on the record yet.
No amounts on the record yet.